Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Elevation Oncology Q3 EPS $(1.67) Down From $(0.53) YoY

Elevation Oncology (NASDAQ:ELEV) reported quarterly losses of $(1.67) per share. This is a 215.09 percent decrease over losses of $(0.53) per share from the same period last year.
byBenzinga Newsdesk
November 3, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

Elevation Oncology (NASDAQ:ELEV) reported quarterly losses of $(1.67) per share. This is a 215.09 percent decrease over losses of $(0.53) per share from the same period last year.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

What’s Going On With Marathon Digital And Riot Platforms Stock?

By Erica Kollmann
April 10, 10:43 AM
Bitcoin miners are preparing for the upcoming halving event, projected to take place on April 20. The CEOs of Riot Platforms and Marathon Digital shared insights on their strategies exclusively with Benzinga. "The Halving immediately cuts revenue in half while doubling costs for miners," Riot CEO Jason Les said. "Depending on your power cost and machine efficiency, some miners will be uneconomic and will be forced to shut off, decreasing network hash rate by at least 5% and possibly more depending on the trend for BTC prices."

MARA